Suppr超能文献

牛奶中合成维生素 B12 和膳食维生素 B12 的生物等效性比较:素食印度人的前瞻性研究。

Comparative Bioavailability of Synthetic B12 and Dietary Vitamin B12 Present in Cow and Buffalo Milk: A Prospective Study in Lactovegetarian Indians.

机构信息

Department of Pathology, Deenanath Mangeshkar Hospital and Research Center, Pune 411004, India.

Department of Clinical Biochemistry and Institute of Clinical Medicine, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.

出版信息

Nutrients. 2019 Feb 1;11(2):304. doi: 10.3390/nu11020304.

Abstract

We assessed improvements in the vitamin B12 status of Indian lactovegetarians receiving four weeks supplementation with natural B12 in milk versus cyano-B12 in capsules. Three groups ( = 22, 23, 22) received daily oral doses of cyano-B12 (2 × 0.76 µg) or milk (2 × 200 mL) from a cow or buffalo (amounting to B12 ≈ 2 × 0.76 µg). Their blood was examined at baseline and each following week. The baselines (median (min/max)) indicated a low B12 status: plasma B12 (116(51/314)) pmol/L, holotranscobalamin (holoTC) (30(7/119)) pmol/L, total homocysteine (Hcy) (24(10/118)) µmol/L, methylmalonic acid (MMA) (0.58(0.15/2.2)) µmol/L and combined B12 index (cB12) (-1.32 - (-3.12/+0.29)). Shifts from the baselines (B12, holoTC, cB12) and ratios to the baselines (Hcy, MMA) were analyzed over time. The cyano-B12 treatment gave more total B12 in plasma at week one (+29 pmol/L, = 0.004) but showed no further increase. Other biomarkers changed more comparably between the three groups ( ≥ 0.05): holoTC showed a transient spike that leveled off, Hcy finally decreased to 0.8 × baseline, while MMA showed marginal changes. The combined indexes improved comparably ( = 0.6) in all groups (+0.2(-0.3/+0.9), ≤ 0.002). In conclusion, the tested formulations similarly improved B12 status, but did not normalize it.

摘要

我们评估了印度严格素食者在四周内分别接受牛奶中天然 B12 与胶囊中氰钴胺(cyano-B12)补充后维生素 B12 状况的改善情况。三组(n = 22、23、22)分别接受每日口服剂量的氰钴胺(2 × 0.76 µg)或来自奶牛或水牛的牛奶(2 × 200 mL,B12 量约为 2 × 0.76 µg)。他们的血液在基线和之后每周进行检查。基线(中位数(最小/最大))显示出低 B12 状态:血浆 B12(116(51/314))pmol/L,全钴胺素(holoTC)(30(7/119))pmol/L,总同型半胱氨酸(Hcy)(24(10/118))µmol/L,甲基丙二酸(MMA)(0.58(0.15/2.2))µmol/L 和综合 B12 指数(cB12)(-1.32-(-3.12/+0.29))。分析了从基线(B12、holoTC、cB12)的变化和与基线的比值(Hcy、MMA)随时间的变化。氰钴胺治疗在第 1 周使血浆中的总 B12 增加了 29 pmol/L(P = 0.004),但没有进一步增加。其他生物标志物在三组之间变化更为相似(≥0.05):holoTC 表现出短暂的尖峰,随后稳定下来,Hcy 最终降至 0.8×基线,而 MMA 则略有变化。所有组的综合指数均得到了相似的改善(P = 0.6)(+0.2(-0.3/+0.9),P ≤ 0.002)。总之,测试的配方同样改善了 B12 状况,但没有使其正常化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd2f/6412291/a1d385c723fb/nutrients-11-00304-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验